Loading...
•
Oct 02, 2021
Thermo Fisher Q3 2021 Earnings Report
Thermo Fisher Scientific reported an increase in revenue and adjusted EPS for the third quarter of 2021, driven by strong performance across its business segments.
Key Takeaways
Thermo Fisher Scientific reported a 9% increase in revenue to $9.33 billion for the third quarter of 2021. GAAP diluted EPS was $4.79, and adjusted EPS was $5.76. The company is raising its 2021 revenue and earnings guidance.
Third quarter revenue increased 9% to $9.33 billion.
Third quarter GAAP diluted earnings per share (EPS) was $4.79.
Third quarter adjusted EPS was $5.76.
The company is raising its revenue guidance by $1.2 billion to $37.1 billion and its adjusted EPS guidance by $1.30 to $23.37 for 2021.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
Thermo Fisher is raising its 2021 revenue and earnings guidance.
Positive Outlook
- Raising revenue guidance by $1.2 billion to $37.1 billion.
- This would result in 15% revenue growth over 2020.
- Raising adjusted EPS guidance by $1.30 to $23.37.
- This would represent 20% growth year over year.
- On track to deliver another outstanding year and set the company up for an even brighter future.
Revenue & Expenses
Visualization of income flow from segment revenue to net income